Jiwu Liao

Dr. Jiwu Liao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
JLJingjing Lin
Jingjing Lin
XHXiaohui Hou
Xiaohui Hou
YLYaxi Liu
Yaxi Liu
YCYixian Cai
Yixian Cai
JPJiyang Pan
Jiyang Pan
JLJiwu Liao
Jiwu Liao
Background: The present study explored the serum glutamate (Glu), glutamine (Gln), glutamic acid dehydrogenase (GAD) concentrations and the mRNA expression levels of the N-methyl-D-aspartate receptor (NMDAR) NR1 subunit in the peripheral blood of patients with insomnia disorder (ID). To our knowledge, this is the first study showing an increase in the mRNA expression levels of the NMDAR NR1 subunit in patients with ID.Methods: This study included 30 ID patients and 30 matched healthy controls. We investigated the demographic and illness information and assessed subjective sleep quality using the Pittsburgh Sleep Quality Index. The Hamilton Depression Scale-17 and Hamilton Anxiety Scale were used to evaluate the patients’ symptoms of depression and anxiety, respectively. The quantifications of Glu, Gln and GAD concentrations were performed by Enzyme-linked immunosorbent assay (ELISA). Real-time PCR was used to detect the mRNA expression levels of the NMDAR NR1 subunit in peripheral blood.Results: Compared with the healthy control group, the serum Glu concentrations and the mRNA expression levels of the NMDAR NR1 subunit in the ID group were significantly higher. However, there was no significant difference in Gln and GAD between the two groups. The receiver operating characteristic (ROC) analysis showed that the mRNA expression levels of the NMDAR NR1 subunit could distinguish ID patients from healthy individuals (area under the curve: 0.758; sensitivity: 73.3%; specificity: 76.7%). A negative correlation was found between the mRNA expression levels of the NMDAR NR1 subunit for age, total duration of illness, and age of first onset in the ID group, whereas a positive correlation was detected for daytime dysfunction.Conclusion: Glutamatergic neurotransmission was abnormal in ID patients. Additionally, the mRNA expression levels of the NMDAR NR1 subunit appeared to have potential as a clinical biomarker for ID. However, the sample size of our study was limited, and future studies with larger sample sizes are needed to further validate and explore the mechanisms involved and to assess the reliability of the biomarker.

25 February 2026 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
YZYongchang Zhang
Yongchang Zhang
PMPing Ma
Ping Ma
HYHaihua Yang
Haihua Yang
SWSisi Wang
Sisi Wang
CLCongrui Li
Congrui Li
JLJiwu Liao
Jiwu Liao
Sleep disturbances have increasingly been linked to dysregulation of the immune-inflammatory system. However, evidence regarding such alterations in patien

28 October 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
XFXiaoxuan Fan
Xiaoxuan Fan
XSXian Shi
Xian Shi
FDFangyi Deng
Fangyi Deng
YCYixian Cai
Yixian Cai
YLYaxi Liu
Yaxi Liu
JPJiyang Pan
Jiyang Pan
Bipolar disorder (BD) is a psychiatric disorder with a high prevalence of suicidal ideation (SI). While the relationship between BD and the endocrine system is well established, the influence of neuroendocrine hormones on SI during depressive episodes remains poorly understood. This cross-sectional study aimed to identify high-risk neuroendocrine factors for SI and evaluate their predictive efficacy using machine learning techniques. Data were obtained from the electronic medical records of patients hospitalized for BD depressive episodes at The First Affiliated Hospital of Jinan University in Guangzhou, Guangdong Province, China between January 1, 2017, and October 31, 2022. Of 635 eligible patients, 380 exhibited SI. In the multivariate analysis, lower levels of FT4 (OR = 0.925; 95% CI = 0.869–0.986; P = 0.017) and testosterone (OR = 0.799; 95% CI = 0.642–0.993; P = 0.043) were significantly associated with an increased risk of SI. Additionally, an earlier age of onset (OR = 0.936; 95% CI = 0.897–0.977; P = 0.002) and the presence of psychotic symptoms contributed to a higher risk of SI. Furthermore, we developed a supervised learning model—Naive Bayes classifier. The model identified age of onset as a key predictor of SI during depressive episodes of BD, highlighting its importance as the most relevant predictive variable for distinguishing patients at risk of SI. These findings could help clinicians more accurately identify BD patients with higher suicide risk, thereby improving diagnostic sensitivity for this disorder.